GGrantIndex
← Leaderboards

Susan Gail Sherman

Johns Hopkins University

$20,850,700
Attributed
$20,850,700
Total exposure
11
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.8M · FY200825
$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,850,700 · 11

By mechanism

R01$19,152,272 · 7
R21$798,178 · 2
R34$736,500 · 1
R03$163,750 · 1

Top collaborators

No co-investigators on record.

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Baltimore

Research focus

BaltimoreInterviewCommunitiesDrug UsageInnovationRisk BehaviorsReportingCitiesMarylandBaseSamplingDesignCohortHiv/StdParticipantEnvironmentSex BehaviorCondomsEpidemicPeerRisk ReductionAids PreventionIncidenceFollow-Up

Grant awards (41)

Implementing and evaluating the impact of novel mobile harm reduction services on overdose among women who use drugs: The SHOUT study.$734,931
R01 · FY2025 · DA · contact PI
Impact of a novel HIV peer navigationand overdose prevention intervention on engagement in the HIV prevention and treatment cascade.$702,773
R01 · FY2025 · DA · contact PI
Impact of a novel HIV peer navigationand overdose prevention intervention on engagement in the HIV prevention and treatment cascade.$910,251
R01 · FY2024 · DA · contact PI
Impact of a novel HIV peer navigationand overdose prevention intervention on engagement in the HIV prevention and treatment cascade.$155,547
R01 · FY2024 · DA · contact PI
Impact of a novel HIV peer navigationand overdose prevention intervention on engagement in the HIV prevention and treatment cascade.$930,322
R01 · FY2023 · DA · contact PI
A structural HIV prevention intervention targeting high-risk women$140,846
R01 · FY2023 · DA · contact PI
Implementing and evaluating the impact of novel mobile harm reduction services on overdose among women who use drugs: The SHOUT study.$2,289,649
R01 · FY2022 · DA · contact PI
Impact of a novel HIV peer navigationand overdose prevention intervention on engagement in the HIV prevention and treatment cascade.$897,928
R01 · FY2022 · DA · contact PI
Exploring barriers and facilitators to women who use drugs (WWUD) awareness, acceptance and uptake of COVID-19 testing, the CARE study.$625,929
R01 · FY2022 · DA · contact PI
Impact of a novel HIV peer navigationand overdose prevention intervention on engagement in the HIV prevention and treatment cascade.$794,472
R01 · FY2021 · DA · contact PI
Exploring barriers and facilitators to women who use drugs (WWUD) awareness, acceptance and uptake of COVID-19 testing, the CARE study.$654,592
R01 · FY2021 · DA · contact PI
C2SPARC: Implementing mobile, POC COVID-19 testing in partnership with a community-based organization to reach women who use drugs.$451,330
R01 · FY2021 · DA · contact PI
Detecting Illicit Fentanyl and its Analogues: a Validation Study$81,875
R03 · FY2021 · DA · contact PI
A structural HIV prevention intervention targeting high-risk women$551,515
R01 · FY2020 · DA · contact PI
A structural HIV prevention intervention targeting high-risk women$154,040
R01 · FY2020 · DA · contact PI
Detecting Illicit Fentanyl and its Analogues: a Validation Study$81,875
R03 · FY2020 · DA · contact PI
A structural HIV prevention intervention targeting high-risk women$643,869
R01 · FY2019 · DA · contact PI
Developing a PrEP Adherence Intervention Targeting At-Risk and Substance Using Women$245,625
R34 · FY2019 · DA · contact PI
The HIV risk environment of high-risk women: Interaction with public safety$686,394
R01 · FY2018 · DA · contact PI
A structural HIV prevention intervention targeting high-risk women$677,898
R01 · FY2018 · DA · contact PI
Developing a PrEP Adherence Intervention Targeting At-Risk and Substance Using Women$245,625
R34 · FY2018 · DA · contact PI
The HIV risk environment of high-risk women: Interaction with public safety$699,269
R01 · FY2017 · DA · contact PI
A structural HIV prevention intervention targeting high-risk women$690,901
R01 · FY2017 · DA · contact PI
Developing a PrEP Adherence Intervention Targeting At-Risk and Substance Using Women$245,250
R34 · FY2017 · DA · contact PI
A structural HIV prevention intervention targeting high-risk women$730,404
R01 · FY2016 · DA · contact PI
The HIV risk environment of high-risk women: Interaction with public safety$628,724
R01 · FY2016 · DA · contact PI
The HIV risk environment of high-risk women: Interaction with public safety$99,999
R01 · FY2016 · DA · contact PI
The HIV risk environment of high-risk women: Interaction with public safety$640,011
R01 · FY2015 · DA · contact PI
A feasibility study of the HIV/STI risk environment of vulnerable women$196,425
R21 · FY2014 · DA · contact PI
Gender Norms and Partner Selection: HIV/STI Risk Among urban Youth$257,199
R01 · FY2013 · HD · contact PI
A feasibility study of the HIV/STI risk environment of vulnerable women$235,710
R21 · FY2013 · DA · contact PI
Gender Norms and Partner Selection: HIV/STI Risk Among urban Youth$507,085
R01 · FY2012 · HD · contact PI
Gender Norms and Partner Selection: HIV/STI Risk Among urban Youth$510,304
R01 · FY2011 · HD · contact PI
" Evaluating a Microeconomic Intervention for High Risk Women in India"$605,627
R01 · FY2010 · MH · contact PI
Gender Norms and Partner Selection: HIV/STI Risk Among urban Youth$497,730
R01 · FY2010 · HD · contact PI
Gender Norms and Partner Selection: HIV/STI Risk Among urban Youth$394,825
R01 · FY2009 · HD · contact PI
The Effects of new alcohol restrictions on sexual behaviors of Thai underage yout$158,982
R21 · FY2009 · AA · contact PI
The Effects of new alcohol restrictions on sexual behaviors of Thai underage yout$207,061
R21 · FY2008 · AA · contact PI
HIV BEHAVIORS IN INJECTING AND NONINJECTING DRUG USERS$90,879
R01 · FY2003 · DA
HIV BEHAVIORS IN INJECTING AND NONINJECTING DRUG USERS$380,343
R01 · FY2002 · DA
HIV BEHAVIORS IN INJECTING AND NONINJECTING DRUG USERS$416,686
R01 · FY2001 · DA